<DOC>
	<DOCNO>NCT01480219</DOCNO>
	<brief_summary>The primary objective study ass relationship ( crude adjust ) voriconazole utilization development non-melanoma skin cancer among adult patient receive lung heart/lung transplant continuously enrol large U.S. commercial health plan .</brief_summary>
	<brief_title>Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients , 2002-2009g</brief_title>
	<detailed_description>N/A . All patient age 18 old receive lung heart/lung transplant January 1 , 2002 December 31 , 2009 MarketScan database sample .</detailed_description>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Patients age 18 old receive lung heart/lung transplant January 1 , 2002 December 31 , 2009 MarketScan database initially include study . Patients young 18 year age enrol least 180 day 180 day date transplant exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>voriconazole</keyword>
	<keyword>non-melanoma skin cancer</keyword>
	<keyword>confound</keyword>
	<keyword>statistical adjustment</keyword>
	<keyword>risk adjustment</keyword>
	<keyword>lung transplant</keyword>
	<keyword>heart/lung transplant</keyword>
	<keyword>immunosuppression</keyword>
</DOC>